Free Speech Challenges to the Inflation Reduction Act

Free Speech Challenges to the Inflation Reduction Act

This Viewpoint looks at the lawsuits brought by pharmaceutical companies to challenge the Inflation Reduction Act of 2022, in particular claims under the First Amendment’s protection of free speech.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA : the journal of the American Medical Association 2023-10, Vol.330 (13), p.1229-1230
Hauptverfasser: Tu, S. Sean, Tushnet, Rebecca
Format: Artikel
Sprache:eng
Schlagworte:
Litigation
Pharmaceutical industry
Reduction
Speech
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This Viewpoint looks at the lawsuits brought by pharmaceutical companies to challenge the Inflation Reduction Act of 2022, in particular claims under the First Amendment’s protection of free speech.
ISSN:0098-7484
1538-3598
DOI:10.1001/jama.2023.17974